The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: methylprednisolone     Quarter: 2016Q3

Total Records: 857     Number of Pages: 43

DRUGNAME PT EventCount
METHYLPREDNISOLONE. Cystitis haemorrhagic 4
METHYLPREDNISOLONE. Cytomegalovirus colitis 4
METHYLPREDNISOLONE. Disseminated intravascular coagulation 4
METHYLPREDNISOLONE. Disseminated tuberculosis 4
METHYLPREDNISOLONE. Drug effect incomplete 4
METHYLPREDNISOLONE. Drug-induced liver injury 4
METHYLPREDNISOLONE. Erythema 4
METHYLPREDNISOLONE. Heart rate increased 4
METHYLPREDNISOLONE. Hepatocellular injury 4
METHYLPREDNISOLONE. Immunosuppression 4
METHYLPREDNISOLONE. Insomnia 4
METHYLPREDNISOLONE. Intra-abdominal haemorrhage 4
METHYLPREDNISOLONE. Live birth 4
METHYLPREDNISOLONE. Low density lipoprotein increased 4
METHYLPREDNISOLONE. Neutropenia 4
METHYLPREDNISOLONE. Neutrophil count decreased 4
METHYLPREDNISOLONE. Peripheral swelling 4
METHYLPREDNISOLONE. Platelet count increased 4
METHYLPREDNISOLONE. Premature delivery 4
METHYLPREDNISOLONE. Pulmonary oedema 4

Total Records: 857     Number of Pages: 43